Merck Other Non-Current Liabilities 2010-2024 | MRK

  • Merck other non-current liabilities for 2024 were $6.465B, a 26.47% decline from 2023.
  • Merck other non-current liabilities for 2023 were $8.792B, a 5.63% increase from 2022.
  • Merck other non-current liabilities for 2022 were $8.323B, a 11.78% decline from 2021.

Quarterly Chart

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B